Article
Mutations of the serine protease CAP1/Prss8 lead to reduced embryonic viability, skin defects, and decreased ENaC activity.
Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland.
American Journal Of Pathology (impact factor:
4.89).
06/2012;
181(2):605-15.
DOI:10.1016/j.ajpath.2012.05.007
pp.605-15
Source: PubMed
-
Citations (0)
-
Cited In (0)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
body weight
CAP1/Prss8 mutant proteins
CAP1/Prss8 mutations
control littermates
different effectors
embryonic viability
epithelial sodium channel ENaC
functional evidence
G54-P57 deletion mutations
glycosylation state
junction proteins
membrane-bound serine protease
mouse frizzy
profilaggrin polypeptide
protease-activated receptor PAR2
protein structure
similar histologic aberrations
skin phenotypes
two mutant proteins
whole organism